A dose-ranging and safety study of candesartan cilexetil in hypertensive pediatric subjects 6 to less than 17 years of age: a 4-week, multinational, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 17 Dec 2007 Status changed from in progress to completed.
- 14 Nov 2005 New trial record.